Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE

Over half of multiple sclerosis (MS) patients experience cognitive deficits, including learning and memory dysfunction, and the mechanisms underlying these deficits remain poorly understood. Neuronal injury and synaptic loss have been shown to occur within the hippocampus in other neurodegenerative disease models, and these pathologies have been correlated with cognitive impairment. Whether hippocampal abnormalities occur in MS models is unknown. Using experimental autoimmune encephalomyelitis (EAE), we evaluated hippocampal neurodegeneration and inflammation during disease. Hippocampal pathology began early in EAE disease course, and included decreases in CA1 pyramidal layer volume, loss of inhibitory interneurons and increased cell death of neurons and glia. It is interesting to note that these effects occurred in the presence of chronic microglial activation, with a relative paucity of infiltrating blood-borne immune cells. Widespread diffuse demyelination occurred in the hippocampus, but there was no significant decrease in axonal density. Furthermore, there was a significant reduction in pre-synaptic puncta and synaptic protein expression within the hippocampus, as well as impaired performance on a hippocampal-dependent spatial learning task. Our results demonstrate that neurodegenerative changes occur in the hippocampus during autoimmune-mediated demyelinating disease. This work establishes a preclinical model for assessing treatments targeted toward preventing hippocampal neuropathology and dysfunction in MS.

[1]  D. Bennett,et al.  Paradoxical Upregulation of Glutamatergic Presynaptic Boutons during Mild Cognitive Impairment , 2007, The Journal of Neuroscience.

[2]  F. Fazio,et al.  Functional Basis of Memory Impairment in Multiple Sclerosis: A [18F]FDG PET Study , 1996, NeuroImage.

[3]  R. Lisak Neurodegeneration in multiple sclerosis , 2007, Neurology.

[4]  B. Trapp,et al.  Axon Loss in the Spinal Cord Determines Permanent Neurological Disability in an Animal Model of Multiple Sclerosis , 2002, Journal of neuropathology and experimental neurology.

[5]  M. Cynader,et al.  Dendritic and synaptic pathology in experimental autoimmune encephalomyelitis. , 2003, The American journal of pathology.

[6]  D. Lubahn,et al.  Estrogen receptor alpha mediates estrogen's immune protection in autoimmune disease. , 2003, Journal of immunology.

[7]  J K Udupa,et al.  Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. , 2000, Radiology.

[8]  Timothy H Murphy,et al.  Rapid Morphologic Plasticity of Peri-Infarct Dendritic Spines After Focal Ischemic Stroke , 2008, Stroke.

[9]  G. Barrett,et al.  The chronology of age-related spatial learning impairment in two rat strains, as tested by the Barnes maze. , 2009, Behavioral neuroscience.

[10]  W. Brück,et al.  Differential upregulation of heme oxygenase-1 (HSP32) in glial cells after oxidative stress and in demyelinating disorders , 2007, Journal of Molecular Neuroscience.

[11]  Rhonda R. Voskuhl,et al.  Treatment with an Estrogen Receptor α Ligand Is Neuroprotective in Experimental Autoimmune Encephalomyelitis , 2006, The Journal of Neuroscience.

[12]  R. Bronson,et al.  Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing--remitting experimental autoimmune encephalomyelitis. , 2007, Brain : a journal of neurology.

[13]  B. Zlokovic The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.

[14]  M Rovaris,et al.  Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. , 2003, Brain : a journal of neurology.

[15]  H J Gundersen,et al.  The efficiency of systematic sampling in stereology and its prediction * , 1987, Journal of microscopy.

[16]  B. Mallon,et al.  Overexpression of the 3′-Untranslated Region of Myelin Proteolipid Protein mRNA Leads to Reduced Expression of Endogenous Proteolipid mRNA , 2002, Neurochemical Research.

[17]  H. Gendelman,et al.  Macrophage‐induced inflammation affects hippocampal plasticity and neuronal development in a murine model of HIV‐1 encephalitis , 2005, Glia.

[18]  D. Keating Mitochondrial dysfunction, oxidative stress, regulation of exocytosis and their relevance to neurodegenerative diseases , 2007, Journal of neurochemistry.

[19]  I. Magnano,et al.  Cognitive impairment and neurophysiological correlates in MS , 2006, Journal of the Neurological Sciences.

[20]  N. Hattori,et al.  Induction and selective accumulation of mutant ubiquitin in CA1 pyramidal neurons after transient global ischemia , 2007, Neuroscience.

[21]  John A Todd,et al.  Genetic Analysis of Autoimmune Disease , 1996, Cell.

[22]  Stephen M. Rao,et al.  Neuropsychology of multiple sclerosis. , 1995, Current opinion in neurology.

[23]  D. Centonze,et al.  Inflammation Triggers Synaptic Alteration and Degeneration in Experimental Autoimmune Encephalomyelitis , 2009, The Journal of Neuroscience.

[24]  P. Matthews,et al.  Thalamic neurodegeneration in multiple sclerosis , 2002, Annals of neurology.

[25]  J. Geurts,et al.  Grey matter pathology in multiple sclerosis , 2006, Acta neurologica Scandinavica. Supplementum.

[26]  J. Macdonald,et al.  Paradox of Ca2+ signaling, cell death and stroke , 2006, Trends in Neurosciences.

[27]  Richard Nicholas,et al.  Substantial Archaeocortical Atrophy and Neuronal Loss in Multiple Sclerosis , 2009, Brain pathology.

[28]  G. Barrett,et al.  Effects of estrogen on basal forebrain cholinergic neurons and spatial learning , 2008, Journal of neuroscience research.

[29]  B. Becher,et al.  Experimental autoimmune encephalomyelitis repressed by microglial paralysis , 2005, Nature Medicine.

[30]  Richard L. M. Faull,et al.  The effect of neurodegenerative diseases on the subventricular zone , 2007, Nature Reviews Neuroscience.

[31]  Frederik Barkhof,et al.  Grey matter pathology in multiple sclerosis , 2008, The Lancet Neurology.

[32]  P M Matthews,et al.  Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. , 2001, Archives of neurology.

[33]  Y. Shoenfeld,et al.  MMP-2, VCAM-1 and NCAM-1 expression in the brain of rats with experimental autoimmune encephalomyelitis as a trigger mechanism for synaptic plasticity and pathology , 2006, Journal of Neuroimmunology.

[34]  M. J. Bellizzi,et al.  Protecting the Synapse: Evidence for a Rational Strategy to Treat HIV-1 Associated Neurologic Disease , 2006, Journal of Neuroimmune Pharmacology.

[35]  L M Cruz-Orive,et al.  Precision of Cavalieri sections and slices with local errors , 1999, Journal of microscopy.

[36]  Bruce D. Trapp,et al.  Pathogenesis of axonal and neuronal damage in multiple sclerosis , 2007, Neurology.

[37]  B. Becher,et al.  Experimental autoimmune encephalomyelitis repressed by microglial paralysis (vol 11, pg 146, 2005) , 2005 .

[38]  C. Pettinelli,et al.  Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes. , 1981, Journal of immunology.

[39]  R. Allegri,et al.  Differential patterns of memory performance in relapsing, remitting and secondary progressive multiple sclerosis. , 2006, Neurology India.

[40]  R. Giffard,et al.  Selective Dysfunction of Hippocampal CA1 Astrocytes Contributes to Delayed Neuronal Damage after Transient Forebrain Ischemia , 2007, The Journal of Neuroscience.

[41]  M. E. Corcoran,et al.  Relations between Brain Pathology and Temporal Lobe Epilepsy , 2002, The Journal of Neuroscience.

[42]  B. Fuss,et al.  Normal CNS Myelination in Transgenic Mice Overexpressing MHC Class I H-2Ld in Oligodendrocytes , 2001, Molecular and Cellular Neuroscience.

[43]  Dennis B. Lubahn,et al.  Estrogen Receptor α Mediates Estrogen’s Immune Protection in Autoimmune Disease , 2003, The Journal of Immunology.

[44]  G. Lynch,et al.  Arg-Gly-Asp-Ser-Selective Adhesion and the Stabilization of Long-Term Potentiation: Pharmacological Studies and the Characterization of a Candidate Matrix Receptor , 1997, The Journal of Neuroscience.

[45]  C. Ayata,et al.  Reduction of hippocampal cell death and proteolytic responses in tissue plasminogen activator knockout mice after transient global cerebral ischemia , 2007, Neuroscience.

[46]  R. Chawla,et al.  Hippocampal neurodegeneration in experimental autoimmune encephalomyelitis (EAE): potential role of inflammation activated myeloperoxidase , 2009, Molecular and Cellular Biochemistry.

[47]  D. Pleasure,et al.  Motor neuron pathology in experimental autoimmune encephalomyelitis: studies in THY1-YFP transgenic mice. , 2005, Brain : a journal of neurology.

[48]  Kyle C. Kern,et al.  Regional hippocampal atrophy in multiple sclerosis. , 2008, Brain : a journal of neurology.

[49]  Bernhard Hemmer,et al.  Immunopathogenesis and immunotherapy of multiple sclerosis , 2006, Nature Clinical Practice Neurology.

[50]  N. De Stefano,et al.  Neocortical volume decrease in relapsing–remitting MS patients with mild cognitive impairment , 2004, Neurology.